Growth Hormone Deficiency Market Trends 2015

Global Markets Direct’s, ‘Growth Hormone Deficiency – Pipeline Review, H1 2015′, provides an overview of the Growth Hormone Deficiency’s therapeutic pipeline.

Growth hormone (GH) deficiency is a disorder that involves the pituitary gland which produces growth hormone and other hormones. Pituitary gland is small gland located at the base of the brain. Growth hormone deficiency may be present at birth or may be the result of a medical condition. Growth hormone deficiency is a rare disorder. In Growth hormone deficiency the child will not follow the normal growth curves. Treatment with growth hormone is long-term, often lasting for several years. During this time, the child needs to be seen regularly by the doctor to ensure the treatment is working. The goals of treatment are to increase growth in children and restore energy, metabolism, and body composition. 

This report provides comprehensive information on the therapeutic development for Growth Hormone Deficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Growth Hormone Deficiency and special features on late-stage and discontinued projects.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Complete Report is Available at http://www.rnrmarketresearch.com/growth-hormone-deficiency-pipeline-review-h1-2015-market-report.html .

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope:

• The report provides a snapshot of the global therapeutic landscape of Growth Hormone Deficiency.
• The report reviews key pipeline products under drug profile section which includes product description, MoA and R&D brief, licensing and collaboration details & other developmental activities.
• The report reviews key players involved in the therapeutics development for Growth Hormone Deficiency and enlists all their major and minor projects.
• The report summarizes all the dormant and discontinued pipeline projects.
• A review of the Growth Hormone Deficiency products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages.

Order a Purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=269550 . (This is a premium report priced at US$2000 for a single user License.)

Reasons to Buy:

• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Develop strategic initiatives by understanding the focus areas of leading companies.
• Identify and understand important and diverse types of therapeutics under development for Growth Hormone Deficiency.
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline.
• Devise corrective measures for pipeline projects by understanding Growth Hormone Deficiency pipeline depth and focus of Indication therapeutics.

Explore more reports on Pharmaceuticals at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals .

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.